Validating a bimodal intravascular ultrasound (IVUS) and near-infrared fluorescence (NIRF) catheter for atherosclerotic plaque detection in rabbits

Biomedical Optics Express

Volumn 6, Issue 10, 2015, Pages 3989-3999

  Abran, Maxime ^a,b   Stähli, Barbara E ^b   Merlet, Nolwenn ^b   Mihalache Avram, Teodora ^b   Mecteau, Mélanie ^b   Rhéaume, Eric ^b,c   Busseuil, David ^b   Tardif, Jean Claude ^b,c   Lesage, Frédéric ^a,b  

^a ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETERS; DISEASES; INFRARED DEVICES; ULTRASONIC APPLICATIONS; ULTRASONIC IMAGING;

ATHEROSCLEROTIC PLAQUE; ATHEROSCLEROTIC PLAQUE DETECTION; CORONARY ARTERY DISEASE; INTRAVASCULAR ULTRASOUND; INTRAVASCULAR ULTRASOUND IMAGING; MULTI-MODALITY IMAGING SYSTEMS; NEAR-INFRARED FLUORESCENCE; PLAQUE CHARACTERIZATIONS;

FLUORESCENCE;

INDOCYANINE GREEN;

ALGORITHM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BALLOON DILATATION; EXPERIMENTAL BALLOON CATHETER INJURY; FLUORESCENCE IMAGING; FLUORESCENCE IMAGING SYSTEM; IMAGE ANALYSIS; INFORMATION PROCESSING; INTRAVASCULAR ULTRASOUND SYSTEM; LIGHT RELATED PHENOMENA; MALE; NEAR INFRARED FLUORESCENCE CATHETER; NONHUMAN; SIGNAL DETECTION; SIGNAL PROCESSING; VALIDATION STUDY;

EID: 84948734708     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.6.003989     Document Type: Article

References (31)

1. M. D. Huffman, D. M. Lloyd-Jones, H. Ning, D. R. Labarthe, M. Guzman Castillo, M. O'Flaherty, E. S. Ford, and S. Capewell, Quantifying options for reducing coronary heart disease mortality by 2020, Circulation 127(25), 2477-2484 (2013).
2. P. Libby, Inflammation in atherosclerosis, Nature 420(6917), 868-874 (2002).
3. P. Libby, Atherosclerosis: disease biology affecting the coronary vasculature, Am. J. Cardiol. 98(12 12A), 3Q-9Q (2006).
4. P. Libby, Inflammation in atherosclerosis, Arterioscler. Thromb. Vasc. Biol. 32(9), 2045-2051 (2012).
5. J.-C. Tardif, J. Grégoire, P. L. L'Allier, R. Ibrahim, M.-A. Lavoie, M. LeMay, E. Cohen, S. Levesque, P.-F. Keller, T. Heinonen, and M.-C. Guertin, Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound, Am. J. Cardiol. 98(1), 23-27 (2006).
6. S.-J. Kang, G. S. Mintz, T. Akasaka, D.-W. Park, J.-Y. Lee, W.-J. Kim, S.-W. Lee, Y.-H. Kim, C. Whan Lee, S.-W. Park, and S.-J. Park, Optical coherence tomographic analysis of in-stent neoatherosclerosis after drugeluting stent implantation, Circulation 123(25), 2954-2963 (2011).
7. S. Tahara, T. Morooka, Z. Wang, H. G. Bezerra, A. M. Rollins, D. I. Simon, and M. A. Costa, Intravascular optical coherence tomography detection of atherosclerosis and inflammation in murine aorta, Arterioscler. Thromb. Vasc. Biol. 32(5), 1150-1157 (2012).
8. S. E. Nissen and P. Yock, Intravascular ultrasound: novel pathophysiological insights and current clinical applications, Circulation 103(4), 604-616 (2001).
9. F. A. Jaffer, M. A. Calfon, A. Rosenthal, G. Mallas, R. N. Razansky, A. Mauskapf, R. Weissleder, P. Libby, and V. Ntziachristos, Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury, J. Am. Coll. Cardiol. 57(25), 2516-2526 (2011).
10. F. A. Jaffer, C. Vinegoni, M. C. John, E. Aikawa, H. K. Gold, A. V. Finn, V. Ntziachristos, P. Libby, and R. Weissleder, Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis, Circulation 118(18), 1802-1809 (2008).
11. M. Nahrendorf, F. A. Jaffer, K. A. Kelly, D. E. Sosnovik, E. Aikawa, P. Libby, and R. Weissleder, Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis, Circulation 114(14), 1504-1511 (2006).
12. L. Rouleau, R. Berti, V. W. K. Ng, C. Matteau-Pelletier, T. Lam, P. Saboural, A. K. Kakkar, F. Lesage, E. Rhéaume, and J.-C. Tardif, VCAM-1-targeting gold nanoshell probe for photoacoustic imaging of atherosclerotic plaque in mice, Contrast Media Mol. Imaging 8(1), 27-39 (2013).
13. B. M. Wallis de Vries, J.-L. Hillebrands, G. M. van Dam, R. A. Tio, J. S. de Jong, R. H. J. A. Slart, and C. J. Zeebregts, Images in cardiovascular medicine. Multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe, Circulation 119(20), e534-e536 (2009).
14. C. Vinegoni, I. Botnaru, E. Aikawa, M. A. Calfon, Y. Iwamoto, E. J. Folco, V. Ntziachristos, R. Weissleder, P. Libby, and F. A. Jaffer, Indocyanine Green Enables Near-Infrared Fluorescence Imaging of Lipid-Rich, Inflamed Atherosclerotic Plaques, Sci. Transl. Med. 3(84), 84-45 (2011).
15. J. Caesar, S. Shaldon, L. Chiandussi, L. Guevara, and S. Sherlock, The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function, Clin. Sci. 21, 43-57 (1961).
16. R. W. Flower and B. F. Hochheimer, Indocyanine green dye fluorescence and infrared absorption choroidal angiography performed simultaneously with fluorescein angiography, Johns Hopkins Med. J. 138(2), 33-42 (1976).
17. G. J. Ughi, J. Verjans, A. M. Fard, H. Wang, E. Osborn, T. Hara, A. Mauskapf, F. A. Jaffer, and G. J. Tearney, Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging, Int. J. Cardiovasc. Imaging 31, 259-268 (2014).
18. T. Desmettre, J. M. Devoisselle, and S. Mordon, Fluorescence Properties and Metabolic Features of Indocyanine Green (ICG) as Related to Angiography, Surv. Ophthalmol. 45(1), 15-27 (2000).
19. J.-C. Tardif, F. Lesage, F. Harel, P. Romeo, and J. Pressacco, Imaging Biomarkers in Atherosclerosis Trials, Circ Cardiovasc Imaging 4(3), 319-333 (2011).
20. D. N. Stephens, J. Park, Y. Sun, T. Papaioannou, and L. Marcu, Intraluminal fluorescence spectroscopy catheter with ultrasound guidance, J. Biomed. Opt. 14(3), 030505 (2009).
21. A. J. Dixon and J. A. Hossack, Intravascular near-infrared fluorescence catheter with ultrasound guidance and blood attenuation correction, J. Biomed. Opt. 18(5), 056009 (2013).
22. J. Bec, D. M. Ma, D. R. Yankelevich, J. Liu, W. T. Ferrier, J. Southard, and L. Marcu, Multispectral fluorescence lifetime imaging system for intravascular diagnostics with ultrasound guidance: in vivo validation in swine arteries, J. Biophotonics 7(5), 281-285 (2014).
23. M. Abran, G. Cloutier, M. H. Cardinal, B. Chayer, J.-C. Tardif, and F. Lesage, Development of a photoacoustic, ultrasound and fluorescence imaging catheter for the study of atherosclerotic plaque, IEEE Trans. Biomed. Circuits Syst. 8(5), 696-703 (2014).
24. D. T. Delpy, M. Cope, P. van der Zee, S. Arridge, S. Wray, and J. Wyatt, Estimation of optical pathlength through tissue from direct time of flight measurement, Phys. Med. Biol. 33(12), 1433-1442 (1988).
25. D. N. Ku, D. P. Giddens, C. K. Zarins, and S. Glagov, Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress, Arteriosclerosis 5(3), 293-302 (1985).
26. M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, Z. Fayad, P. H. Stone, S. Waxman, P. Raggi, M. Madjid, A. Zarrabi, A. Burke, C. Yuan, P. J. Fitzgerald, D. S. Siscovick, C. L. de Korte, M. Aikawa, K. E. Airaksinen, G. Assmann, C. R. Becker, J. H. Chesebro, A. Farb, Z. S. Galis, C. Jackson, I. K. Jang, W. Koenig, R. A. Lodder, K. March, J. Demirovic, M. Navab, S. G. Priori, M. D. Rekhter, R. Bahr, S. M. Grundy, R. Mehran, A. Colombo, E. Boerwinkle, C. Ballantyne, W. Insull, Jr., R. S. Schwartz, R. Vogel, P. W. Serruys, G. K. Hansson, D. P. Faxon, S. Kaul, H. Drexler, P. Greenland, J. E. Muller, R. Virmani, P. M. Ridker, D. P. Zipes, P. K. Shah, and J. T. Willerson, From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II, Circulation 108(15), 1772-1778 (2003).
27. N. D. Desai, S. Miwa, D. Kodama, G. Cohen, G. T. Christakis, B. S. Goldman, M. O. Baerlocher, M. P. Pelletier, and S. E. Fremes, Improving the quality of coronary bypass surgery with intraoperative angiography: validation of a new technique, J. Am. Coll. Cardiol. 46(8), 1521-1525 (2005).
28. S. Yoneya, T. Saito, Y. Komatsu, I. Koyama, K. Takahashi, and J. Duvoll-Young, Binding properties of indocyanine green in human blood, Invest. Ophthalmol. Vis. Sci. 39(7), 1286-1290 (1998).
29. S. Lee, M. W. Lee, H. S. Cho, J. W. Song, H. S. Nam, D. J. Oh, K. Park, W.-Y. Oh, H. Yoo, and J. W. Kim, Fully integrated high-speed intravascular optical coherence tomography/near-infrared fluorescence structural/molecular imaging in vivo using a clinically available near-infrared fluorescence-emitting indocyanine green to detect inflamed lipid-rich atheromata in coronary-sized vessels, Circ. Cardiovasc. Interv. 7(4), 560-569 (2014).
30. H. Yoo, J. W. Kim, M. Shishkov, E. Namati, T. Morse, R. Shubochkin, J. R. McCarthy, V. Ntziachristos, B. E. Bouma, F. A. Jaffer, and G. J. Tearney, Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo, Nat. Med. 17(12), 1680-1684 (2011).
31. D. Busseuil, Y. Shi, M. Mecteau, G. Brand, A.-E. Kernaleguen, E. Thorin, J.-G. Latour, E. Rhéaume, and J.-C. Tardif, Regression of aortic valve stenosis by ApoA-I mimetic peptide infusions in rabbits, Br. J. Pharmacol. 154(4), 765-773 (2008).